These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9674700

  • 1. Involvement of Myc targets in c-myc and N-myc induced human tumors.
    Ben-Yosef T, Yanuka O, Halle D, Benvenisty N.
    Oncogene; 1998 Jul 16; 17(2):165-71. PubMed ID: 9674700
    [Abstract] [Full Text] [Related]

  • 2. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T, Yanuka O, Benvenisty N.
    Oncogene; 1996 Nov 07; 13(9):1859-66. PubMed ID: 8934531
    [Abstract] [Full Text] [Related]

  • 3. Position and orientation independent transactivation by c-Myc.
    Packham G, Bello-Fernandez C, Cleveland JL.
    Cell Mol Biol Res; 1994 Nov 07; 40(7-8):699-706. PubMed ID: 7787888
    [Abstract] [Full Text] [Related]

  • 4. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
    Schuldiner O, Benvenisty N.
    Oncogene; 2001 Aug 16; 20(36):4984-94. PubMed ID: 11526483
    [Abstract] [Full Text] [Related]

  • 5. Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells.
    Sun SY, Yue P, Shroot B, Hong WK, Lotan R.
    Oncogene; 1999 Jul 01; 18(26):3894-901. PubMed ID: 10445853
    [Abstract] [Full Text] [Related]

  • 6. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP, de Bruijn MJ, Dingjan GM, Beverloo HB, Diepstraten H, Ling KW, Hendriks RW.
    Mol Immunol; 2008 Jun 01; 45(11):3085-95. PubMed ID: 18471881
    [Abstract] [Full Text] [Related]

  • 7. Cdc25 cell-cycle phosphatase as a target of c-myc.
    Galaktionov K, Chen X, Beach D.
    Nature; 1996 Aug 08; 382(6591):511-7. PubMed ID: 8700224
    [Abstract] [Full Text] [Related]

  • 8. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL.
    Cancer Cell; 2005 May 08; 7(5):433-44. PubMed ID: 15894264
    [Abstract] [Full Text] [Related]

  • 9. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R, Carroll WL.
    Cancer; 2003 Aug 15; 98(4):841-53. PubMed ID: 12910530
    [Abstract] [Full Text] [Related]

  • 10. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
    Habel ME, Lemieux R, Jung D.
    J Cell Physiol; 2005 Apr 15; 203(1):277-85. PubMed ID: 15468060
    [Abstract] [Full Text] [Related]

  • 11. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC.
    Oncogene; 1999 Jun 17; 18(24):3564-73. PubMed ID: 10380878
    [Abstract] [Full Text] [Related]

  • 12. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
    Chen J, Chattopadhyay B, Venkatakrishnan G, Ross AH.
    Cell Growth Differ; 1990 Feb 17; 1(2):79-85. PubMed ID: 1964795
    [Abstract] [Full Text] [Related]

  • 13. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
    Rosolen A, Whitesell L, Ikegaki N, Kennett RH, Neckers LM.
    Cancer Res; 1990 Oct 01; 50(19):6316-22. PubMed ID: 2205380
    [Abstract] [Full Text] [Related]

  • 14. Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer.
    Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD, Chen LB.
    Oncogene; 1993 Oct 01; 8(10):2821-6. PubMed ID: 8378090
    [Abstract] [Full Text] [Related]

  • 15. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.
    Ann N Y Acad Sci; 2004 Dec 01; 1028():90-103. PubMed ID: 15650235
    [Abstract] [Full Text] [Related]

  • 16. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M, Seger D, Kreizman T, Badikhi D, Margalit R, Eilam R, Degani H.
    Endocr Relat Cancer; 2009 Sep 01; 16(3):819-34. PubMed ID: 19398483
    [Abstract] [Full Text] [Related]

  • 17. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

  • 18. c-MYC impairs immunogenicity of human B cells.
    Schlee M, Schuhmacher M, Hölzel M, Laux G, Bornkamm GW.
    Adv Cancer Res; 2007 Jan 01; 97():167-88. PubMed ID: 17419945
    [Abstract] [Full Text] [Related]

  • 19. c-Myc induces the expression and activity of ornithine decarboxylase.
    Wagner AJ, Meyers C, Laimins LA, Hay N.
    Cell Growth Differ; 1993 Nov 01; 4(11):879-83. PubMed ID: 8297793
    [Abstract] [Full Text] [Related]

  • 20. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R, Hanf V, Emons G, Gründker C.
    J Pineal Res; 2009 Aug 01; 47(1):23-31. PubMed ID: 19522736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.